Research compound supplied in Australia by Pulse Biolabs for laboratory use. Available in 60mg.
Cerebrolysin is not one peptide but a preparation of many, derived from pig brain. Its research history shows how much harder a mixture is to characterise, and to test, than a single defined compound.
Cerebrolysin is a mixture of small peptides and amino acids produced from porcine brain protein, not a single defined molecule. It is studied for whether such a mixture can mimic the body's own nerve-supporting signals after a stroke or in dementia. The evidence is mainly from human trials of the branded intravenous solution in stroke and vascular dementia patients, with mixed results; a lyophilised listing under the same name cannot be assumed equivalent to that preparation.
Read the full research note →| Presentation | Code | Status | Price |
|---|---|---|---|
| 60mg | CBL60 | In stock | $80 |
No batch-specific test report is currently published for this product. What a report does and does not show.
Supplied as lyophilised (freeze-dried) powder in a sealed vial. Store sealed and protected from light at the conditions stated on the label or supplied specification, and avoid agitation. Solvent and handling after reconstitution are a matter for the laboratory’s own procedures and are not specified here.
No Australian registration for Cerebrolysin was identified. The branded preparation is registered as a prescription medicine in a number of countries, including Russia, parts of Eastern Europe and China, and its manufacturer states it is not approved by the US FDA. The lyophilised material supplied here is not that registered product.
Status checked 2026-09-23. Details and sources in the research note.